Benefits
Blood pressure reduction (extensive trial evidence)
Multiple Kyolic® clinical trials and meta-analyses document blood pressure reduction in adults with elevated BP — typically 7-12 mmHg systolic and 4-7 mmHg diastolic. The trial-grade evidence base for AGE blood pressure effects is built largely on Kyolic® research.
Arterial calcification progression slowing
Landmark Kyolic® trials using serial coronary CT scans showed reduced progression of coronary artery calcification compared to placebo. Disease-modifying evidence rare among supplements; specific to Kyolic® research program.
Cholesterol and lipid improvements
Kyolic® supplementation modestly reduces total cholesterol, LDL cholesterol, and improves HDL ratio in adults with hyperlipidemia. Effect sizes consistent with the broader AGE evidence base; trial-validated for the Kyolic® specifically.
Endothelial function and arterial elasticity
Clinical trials show Kyolic® supports endothelial function and arterial elasticity in adults with cardiovascular risk factors. Mechanism involves nitric oxide pathway support and reduced vascular oxidative stress.
Immune system support
Different Kyolic® formulations target immune support with documented effects on natural killer cell activity and respiratory infection frequency. Less robust than the cardiovascular evidence but supports the broader product line positioning.
850+ published research articles
Wakunaga has supported over 850 published research articles on Kyolic® specifically — unusually deep research investment for a supplement brand. The clinical evidence depth is what distinguishes Kyolic® from generic aged garlic alternatives.
Reproducible SAC standardization
Kyolic® provides consistent S-allyl cysteine content batch-to-batch through the controlled proprietary aging process. Standardization enables consistent clinical effects across trials and supports product-line consumer expectations.
Odorless and well-tolerated for long-term use
Like other quality AGE products, Kyolic® produces no garlic breath or odor and is well-tolerated for long-term use. Practical advantage supporting daily cardiovascular supplementation strategies.
Mechanism of action
S-allyl cysteine bioavailability
Kyolic®'s 20+ month aging process converts unstable allicin into stable, water-soluble S-allyl cysteine (SAC). SAC is much more bioavailable than allicin and provides reproducible plasma levels for clinical effects.
Cardiovascular pathway support
Kyolic® components support nitric oxide pathway, reduce vascular oxidative stress, modulate platelet aggregation, and improve endothelial function. Multi-mechanism cardiovascular support explaining the breadth of clinical evidence.
Antioxidant capacity enhancement
Aged garlic extract has significantly higher antioxidant capacity than raw garlic — the aging process concentrates polyphenols and Maillard reaction products with antioxidant activity. Distinguishes from raw garlic supplements at the chemistry level.
Clinical trials
Kyolic® has supported multiple cardiovascular clinical trials documenting blood pressure reduction, cholesterol improvement, and arterial calcification progression slowing. The trial program depth distinguishes Kyolic® from generic aged garlic in the evidence base.
Landmark trials used serial coronary calcification CT imaging to document Kyolic® effects on coronary artery disease progression. Disease-modifying evidence rare among cardiovascular supplements.
Wakunaga's research investment supports over 850 published research articles on Kyolic® specifically. The clinical evidence depth provides confidence in trial-validated effects across cardiovascular and immune applications.